id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1999-P-3513-0004,FDA,FDA-1999-P-3513,Acknowledgment Letter from FDA DDM to King & Spalding,Other,Acknowledgement Letter/Receipt,2017-07-24T04:00:00Z,2017,7,2017-07-24T04:00:00Z,,2017-07-24T14:51:28Z,,0,0,09000064804f3ef6
FDA-1999-P-3513-0005,FDA,FDA-1999-P-3513,Petition Denial Response Letter from FDA CDER to King & Spalding,Other,Denial of Petition,2017-07-24T04:00:00Z,2017,7,2017-07-24T04:00:00Z,,2017-07-24T14:59:33Z,,0,0,09000064804f3ef7
FDA-1999-P-3513-0002,FDA,FDA-1999-P-3513,"Attachment A Letter from FDA CDER to Endo Pharmaceuticals, Inc. July 26, 1999 re: Citizen Petition from King & Spalding",Supporting & Related Material,Background Material,2017-07-24T04:00:00Z,2017,7,,,2017-07-24T14:44:17Z,,0,0,090000648295d4c1
FDA-1999-P-3513-0003,FDA,FDA-1999-P-3513,Attachment B Proposed Draft Insert and Side by Side Comparison of Oxycodone and Acetaminophen re: Citizen Petition from King & Spalding,Supporting & Related Material,Background Material,2017-07-24T04:00:00Z,2017,7,,,2017-07-24T14:44:04Z,,0,0,090000648295d4c2
FDA-1999-P-3513-0001,FDA,FDA-1999-P-3513,Citizen Petition from King & Spalding,Other,Citizen Petition,2017-07-24T04:00:00Z,2017,7,1999-08-12T04:00:00Z,,2017-07-24T14:36:25Z,,0,0,09000064804f3ef5